Literature DB >> 32441488

Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome.

Orlando Zagaria1, Angelo Ruggiero1, Gabriella Fabbrocini1, Lucia Gallo1, Marco Romanelli2, Claudio Marasca1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32441488      PMCID： PMC7948612          DOI： 10.1111/iwj.13403

Source DB:  PubMed          Journal:  Int Wound J        ISSN： 1742-4801            Impact factor:   3.315


× No keyword cloud information.
  17 in total

Review 1.  Pyoderma gangrenosum: a review of pathogenesis and treatment.

Authors:  Christine Ahn; Deborah Negus; William Huang
Journal:  Expert Rev Clin Immunol       Date:  2018-02-13       Impact factor: 4.473

2.  Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry.

Authors:  V Bettoli; L Naldi; S Cazzaniga; S Zauli; L Atzori; A Borghi; R Capezzera; M Caproni; C Cardinali; V De Vita; M Donini; G Fabbrocini; A Gimma; S Pasquinucci; A Patrizi; A L Pinna; B Raone; M Ricci; A Virgili; R Balestri
Journal:  Br J Dermatol       Date:  2015-11-08       Impact factor: 9.302

3.  Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case.

Authors:  Claudio Marasca; Giuseppina Fontanella; Maria C Annunziata; Dario Marasca; Gabriella Fabbrocini
Journal:  Int Wound J       Date:  2019-04-01       Impact factor: 3.315

Review 4.  PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment.

Authors:  Massimo Cugno; Alessandro Borghi; Angelo V Marzano
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

Review 5.  [Evidence of compression therapy].

Authors:  W Konschake; E Valesky; H Stege; M Jünger
Journal:  Hautarzt       Date:  2017-08       Impact factor: 0.751

Review 6.  Is PASH Syndrome a Biofilm Disease?: A Case Series and Review of the Literature.

Authors:  Joey Karim Ead; Robert J Snyder; Jaime Wise; Cherison Cuffy; Hamed Jafary; Karen Fischborn
Journal:  Wounds       Date:  2018-08       Impact factor: 1.546

7.  Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance.

Authors:  C Marasca; A Masarà; M C Annunziata; V Bettoli; M A Luciano; G Fabbrocini
Journal:  Br J Dermatol       Date:  2019-01-01       Impact factor: 9.302

Review 8.  Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.

Authors:  J Staub; N Pfannschmidt; R Strohal; M Braun-Falco; P Lohse; S Goerdt; M Leverkus
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-10-28       Impact factor: 6.166

9.  Pyoderma gangrenosum - a guide to diagnosis and management .

Authors:  Christina George; Florence Deroide; Malcolm Rustin
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

10.  Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.

Authors:  Anthony D Ormerod; Kim S Thomas; Fiona E Craig; Eleanor Mitchell; Nicola Greenlaw; John Norrie; James M Mason; Shernaz Walton; Graham A Johnston; Hywel C Williams
Journal:  BMJ       Date:  2015-06-12
View more
  1 in total

1.  Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.

Authors:  Jundong Huang; Lemuel Shui-Lun Tsang; Wei Shi; Ji Li
Journal:  Front Med (Lausanne)       Date:  2022-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.